Zurcher Kantonalbank (Zurich Cantonalbank) Vera Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 7,961 shares of VERA stock, worth $218,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,961
Previous 7,527
5.77%
Holding current value
$218,609
Previous $332,000
1.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.8MCall Options Held
78.4KPut Options Held
89.8K-
Avoro Capital Advisors LLC New York, NY5.61MShares$154 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$120 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$91.7 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$81.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$81 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $743M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...